Topics

Food and Drug Administration
Scope maker Olympus expects to settle U.S. claims over marketing
Scope maker Olympus expects to settle U.S. claims over marketing

The manufacturer of endoscopes at the center of a string of deadly superbug outbreaks has set aside nearly $450 million for an expected settlement of a U.S. investigation into its marketing of medical products. Olympus Corp. of Japan did not disclose the details of what federal officials have been investigating other than saying the focus is on possible violations of laws that ban companies from paying kickbacks to doctors and other potential customers. The giant electronics maker said investigators have been looking at its U.S. sales activities from 2006 to 2011. It is not clear what Olympus products may be involved. In recent months, Olympus has come under harsh criticism for failing...

Loading